Loading…
avatar for Raj Puri

Raj Puri

FDA
Director, Division of Cellular and Gene Therapies, OTAT, CBER
Raj K. Puri, M.D., Ph.D. is a director of the Division of Cellular and Gene Therapies (DCGT) in the Office of Tissues and Advanced Therapies (OTAT) at FDA’s Center for Biologics Evaluation and Research (CBER). He has been directing this division for more than16 years. He is also a Chief of Tumor Vaccines and Biotechnology Branch within the same division. Dr. Puri has held various positions in CBER as a reviewer and laboratory chief prior to selection as a division director. Prior to joining FDA/CBER, Dr. Puri was trained at National Cancer Institute’s Surgery Branch in immunotherapy approaches for cancer and at Mayo Clinic, Rochester, Minnesota. At CBER, Dr. Puri oversees evaluation and regulation of advanced therapies including cell and